Choriogonadotropin alfa biosimilar (Dong-A ST)

绒促性素α生物类似药(Dong-A ST)

Report date: 2022/07/04 19:38:02

Base Information

Drug NameChoriogonadotropin alfa biosimilar (Dong-A ST)
Drug Alias Name绒促性素α生物仿制药(Dong-A ST)DA-3803
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionLuteinizing hormone/Choriogonadotropin receptor agonistsOvarian follicle stimulants
TargetsLuteinizing hormone/Choriogonadotropin receptor
Therapy Area/IndicationsInfertility, FemaleInfertilityPolycystic Ovary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFranceMainland China
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesDong-A Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsInfertility, FemaleInfertilityPolycystic Ovary Syndrome

Other Information

ATC CodeG03GA08
Related LinksN/A